Loading resource…

Fortis Hospital, Sher-i-Kashmir Institute of Medical Sciences, MEDICOVER Hospital, AJ Institute of Medical Sciences, Cedar Super Specialty Clinic
Glucocorticoid (GC) therapy is crucial for managing various inflammatory and immunological disorders, but it carries risks of significant side effects, particularly with prolonged use. The document emphasizes the necessity of tapering GC therapy to mitigate risks of adrenal insufficiency and disease flare-ups. It outlines strategies for tapering, including monitoring disease activity and adjusting doses appropriately to support recovery of the HPA axis while maintaining patient safety.
Sign in to open
Answers use this document only.
Your first question is free.
Resources from the same specialty and type. Curated links will replace these when added.
Documents that extend or complement this resource.

DIABETES MELLITUS
Same clinical topic · Endocrinology

Williams Textbook of Endocrinology (2019, Elsevier)
Same clinical topic · Endocrinology

Oxford Desk Reference Endocrinology 1st edition
Same clinical topic · Endocrinology

Practical Clinical Endocrinology Peter Igaz-2021
Same clinical topic · Endocrinology

Endocrine Secrets 8th edition 2026
Same clinical topic · Endocrinology

PHARMACOLOGY OF DIABETES MELLITUS
Same clinical topic · Endocrinology

pharmacology of Diabetes mellitus drugs
Same clinical topic · Endocrinology

THE GLUCOCORTICOID TAPER: A PRIMER FOR THE CLINICIANS
Same clinical topic · Endocrinology

ENDOCRINE MKSAP 19 BOARDBASICS
Same clinical topic · Endocrinology